In the last trading session, 1.47 million shares of the RAPT Therapeutics Inc (NASDAQ:RAPT) were traded, and its beta was -0.38. Most recently the company’s share price was $1.56, and it changed around $0.03 or 1.96% from the last close, which brings the market valuation of the company to $205.93M. RAPT currently trades at a discount to its 52-week high of $9.65, offering almost -518.59% off that amount. The share price’s 52-week low was $0.79, which indicates that the current value has risen by an impressive 49.36% since then. We note from RAPT Therapeutics Inc’s average daily trading volume that its 10-day average is 1.29 million shares, with the 3-month average coming to 1.14 million.
RAPT Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.60. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 4 recommended RAPT as a Hold, whereas 1 deemed it a Buy, and 1 rated it as Underweight. RAPT Therapeutics Inc is expected to report earnings per share of -0.14 for the current quarter.
RAPT Therapeutics Inc (NASDAQ:RAPT) trade information
Instantly RAPT has showed a green trend with a performance of 1.96% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.5700 on recent trading dayincreased the stock’s daily price by 0.64%. The company’s shares are currently down -1.27% year-to-date, but still up 43.12% over the last five days. On the other hand, RAPT Therapeutics Inc (NASDAQ:RAPT) is 32.20% up in the 30-day period. We can see from the shorts that 2.67 million shares have been sold at a short interest cover period of 5.84 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 22.0% from its current value. Analyst projections state that RAPT is forecast to be at a low of $2 and a high of $2.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -10.10%. RAPT Therapeutics Inc earnings are expected to increase by 81.30% in 2025, but the outlook is positive 42.80% per year for the next five years.
RAPT Dividends
RAPT Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-Mar-05.
RAPT Therapeutics Inc (NASDAQ:RAPT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.49% of RAPT Therapeutics Inc shares, and 96.43% of them are in the hands of institutional investors. The stock currently has a share float of 96.90%. RAPT Therapeutics Inc stock is held by 132.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 13.5546% of the shares, which is about 5.24 million shares worth $15.97 million.
VANGUARD GROUP INC, with 8.0472% or 3.11 million shares worth $9.48 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.05 shares worth $1.64 million, making up 0.79% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 766.71 shares worth around $1.2 million, which represents about 0.58% of the total shares outstanding.
